Inventory Turnover (Annual)

Inventory Turnover: A ratio showing how many times a company's inventory is sold and replaced over a period. Calculated as: Cost of Goods Sold / Total Inventory

Phathom Pharmaceuticals, Inc. (PHAT) had Inventory Turnover of 0.14 for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$0.68M
Net Income	$-201.59M
Cost of Goods Sold	$0.17M
Gross Profit	$0.52M
Operating Expenses	$167.99M
Operating Income	$-167.31M
Non-Operating Income/Expense	$-34.28M
Pre-Tax Income	$-201.59M
Normalized Pre-Tax Income	$-201.59M
Income after Taxes	$-201.59M
Income from Continuous Operations	$-201.59M
Consolidated Net Income/Loss	$-201.59M
Normalized Income after Taxes	$-201.59M
EBIT	$-167.31M
EBITDA	$-164.86M
Weighted-Average Shares Outstanding (Basic)	51.29M
Weighted-Average Shares Outstanding (Diluted)	51.29M
Earnings per Share (EPS) (Basic)	$-3.93
Earnings per Share (EPS) (Diluted)	$-3.93
Balance Sheet Financials
Current Assets	$397.43M
Property, Plant, and Equipment	$2.15M
Long-Term Assets	$16.41M
Total Assets	$413.84M
Current Liabilities	$38.78M
Long-Term Debt	$137.84M
Long-Term Liabilities	$447.82M
Total Liabilities	$486.60M
Common Equity	$-72.76M
Tangible Shareholders Equity	$-72.76M
Shareholders Equity	$-72.76M
Common Shares Outstanding	57.97M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-137.58M
Cash Flow from Investing Activities	$-1.63M
Cash Flow from Financial Activities	$367.58M
Beginning Cash	$155.89M
End Cash	$384.26M
Increase/Decrease in Cash	$228.37M
Stock-Based Compensation	$45.02M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	10.25
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.12
Debt to Equity Ratio	-1.89
Gross Margin	75.51%
Operating Margin	-24532.55%
EBIT Margin	-24532.55%
EBITDA Margin	-24173.02%
Pre-Tax Profit Margin	-29558.95%
Profit Margin	-29558.95%
Free Cash Flow	$-139.21M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.00
Inventory Turnover	0.14
Receiveable Turnover	0.42
Days Sales in Receivables	876.11
Return on Equity	277.07%
Return on Tangible Equity	277.07%
Return on Assets	-48.71%
Return on Investments	-309.75%
Book Value Per Share	$-1.26
Free Cash Flow per Share	$-2.71
Operating Cash Flow per Share	$-2.68

Data from Zacks Investment Research, Inc.